Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 1.93 is 4282% above its 5-year average of -0.05, near the high end of its 5-year range (-14.87–1.93).
As of the fiscal period ended Tuesday, June 30, 2026. 182.42% above its 12-month average of -2.34.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.93.
DEBT TO EQUITY RATIO
1.93
DEBT TO EQUITY RATIO AVG TTM
-2.34
DEBT TO EQUITY RATIO AVG 3Y
-0.21
DEBT TO EQUITY RATIO AVG 5Y
-0.05
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+182.42%
CURRENT VS 3Y AVG
+1032.61%
CURRENT VS 5Y AVG
+4282.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
+1653.42%
vs the sector median at left
QT Imaging Holdings, Inc.
Market Cap
$36.76M
Debt to Equity Ratio
1.93
TTM Avg
-2.34
3Y Avg
-0.21
5Y Avg
-0.05
Market Cap
$36.75M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$36.42M
Debt to Equity Ratio
1.78
TTM Avg
8.87
3Y Avg
3.44
5Y Avg
2.59
Market Cap
$37.93M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.02
5Y Avg
0.01
Market Cap
$35.86M
Debt to Equity Ratio
N/A
TTM Avg
0.89
3Y Avg
0.89
5Y Avg
0.89
Market Cap
$35.06M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$38.47M
Debt to Equity Ratio
5.96
TTM Avg
1.96
3Y Avg
1.31
5Y Avg
1.11
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $36.76M | 1.93 | -2.34 | -0.21 | -0.05 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.75M | 0.00 | 0.01 | 0.01 | 0.01 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.42M | 1.78 | 8.87 | 3.44 | 2.59 |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | 0.00 | 0.01 | 0.02 | 0.01 |
| EUDA Health Holdings Limited (EUDA)vs › | $35.86M | N/A | 0.89 | 0.89 | 0.89 |
| DocGo Inc. (DCGO)vs › | $35.62M | 0.22 | 0.19 | 0.15 | 0.15 |
| Nephros, Inc. (NEPH)vs › | $38.32M | 0.07 | 0.13 | 0.17 | 0.16 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | 0.00 | 0.00 | 0.00 | 0.00 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | 5.96 | 1.96 | 1.31 | 1.11 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | 0.00 | 0.00 | 0.00 | 0.00 |
Debt/Equity
1.93
Current Ratio
3.10
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 1.93 |
| 2026-03-31 | 1.53 |
| 2025-12-31 | 0.81 |
| 2025-09-30 | -1.10 |
| 2025-06-30 | -14.87 |
| 2025-03-31 | -0.24 |
| 2024-12-31 | -1.04 |
| 2024-09-30 | -1.13 |
| 2024-06-30 | -1.78 |
| 2024-03-31 | -2.08 |
| 2023-12-31 | 0.29 |
| 2023-09-30 | 0.23 |
| 2023-06-30 | 0.11 |
| 2023-03-31 | 0.08 |
| 2022-12-31 | 0.06 |
| 2022-09-30 | 0.03 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 1.44 |
| 2021-09-30 | 0.00 |
| 2021-02-28 | 8.33 |
